Bentley University - McCallum Graduate School of Business

Bentley University

Pharma, Partnerships and Business Development at Datavant

San Francisco, California, United States

Datavant's mission is to connect the world’s healthcare data. Our goal is to eliminate the silos of data that hold back medical research by creating tools for health care organizations to control the use and security of their data.Datavant’s industry-leading platform is designed to support linking de-identified patient records across data types to support a variety of use cases such as RWE, HEOR, and predictive analytics. Datavant's vision is backed by Roivant Sciences, Softbank, and Founders Fund and is located in San Francisco.

Datavant

Partnerships and Business Development

PainQx is a diagnostic/software company that has developed a next-generation approach to objectively measure chronic pain in humans. PainQx is able to accomplish this by reading neural activity from a patient’s brain and then processing the data through its proprietary algorithm to produce a scaled biomarker that is directly correlated to the chronic pain state in humans.

PainQx

VP of Business Development

Life Science Nation (LSN) is the premier sourcing platform for market intelligence and prospect pipeline development in the life science arena. LSN enables life science professionals to generate a list of qualified global targets that are a fit for their company’s products, services, and fundraising efforts. The ability to generate these Global Target Lists (GTLs) makes life science professionals more effective and efficient. The Life Science Nation Investor Platform is a one of a kind life science-specific investor platform available to scientist/entrepreneurs raising capital. Present and future-looking investor data is collected and curated by LSN’s Investor Research team. LSN developed a multistep process starting with web-research and validation of current and accurate information. This is enhanced by one-on-one conversations that occur every 90 days to identify and update active mandates. Fundraising executives can use the LSN’s Investor Platform to match up with investors that are a fit for their particular stage, sector, or disease area, making the fundraising process more effective and efficient.

Life Science Nation

Founder & VP of Business Development

Abpro specializes in generating custom monoclonal antibodies. The foundation of our technology is the HTP mouse. A proprietary HTP mouse has been genetically engineered to have a boosted immune system to circumvent the shortcomings of the industry’s standard BALB/c mouse, enabling us to offer customers unique advantages. Primarily, we can deliver our clients a more diverse group of antibodies to more epitopes on a given antigen. Our technology has been proven to make antibodies to epitopes which conventional systems have failed. In addition, our HTP mouse can go through immunization rapidly, enabling us to deliver custom made monoclonal hybridomas in 2 months; saving time and money. Our revolutionary technology makes us the most rapid high quality monoclonal antibody provider in the world.

Abpro

Business Development

Actively involved in the fundraising of a $150M fund by sourcing, pitching, and arranging meetings for the firm’s partners. Created a database of 6,000 NE technology and manufacturing companies which was then used to begin a marketing campaign. Participated in the deal flow process by identifying potential companies, performing due diligence, and engaging with owners. Created reports for the firm regarding both the micro, and macro environment of the PE, VC, and Mezzanine debt space.

Arctaris Capital

Analyst (Intern)

Organized member databases, and worked in overall management of the Angel group. Actively engaged in due diligence, recruiting members, participating in screening deal flow, and providing investment analysis.

Alejandro Zamorano